Search Our Website:

George Karavetsos, shareholder in the firm’s FDA & Biotechnology and White Collar, Compliance & Investigations practices, was quoted in The Philadelphia Inquirer article, “These kids signed up to test a COVID-19 vaccine, but it will be months before approval.” George provides insight on what FDA regulators will be looking at when it comes to authorizing COVID-19 vaccines for emergency use in children.